Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 7, 2014; 20(41): 15079-15086
Published online Nov 7, 2014. doi: 10.3748/wjg.v20.i41.15079
Table 1 miRs deregulated in experimental models of non-alcoholic fatty liver disease
Ref.miRmiR regulationExperimental model
[55]miR-122Up-regulationIn vivo: Silencing by antisense-base technology in a diet induced obesity mouse model
[56]miR-122Up-regulationIn vivo: Inhibition by antisense oligonucleotides “locked nucleic acid” (LNA) in monkeys
[59]miR-34a miR155 miR-200b miR-221Up-regulationIn vivo: C57BL/6J and DBA/2J methyl-deficient diet mice fed
miR-29c miR-122 miR-192 miR-203Down-regulation
[60]miR-200a miR-200b miR-429Up-regulationIn vivo: HFD/HFr fed rats
miR-27 miR-122 miR-451Down-regulation
[61]miR 200b miR 155Up-regulationIn vivo: HFD/HFr fed rats In vitro: HepG2 hepatoma cell line upon FFA stimulation
[62]miR-15bUp-regulationIn vivo: HFD fed rats In vitro: L02 human hepatocyte cell line treated with palmitate
[63]miR-10bUp-regulationIn vitro: Steatotic model of human L02 hepatocytes
[66]miR-103 mi-R107Up-regulationIn vivo: Dietary obese rats
[71,72]miR-34aUp-regulationIn vivo: Dietary obese mice